Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide during Cardiac MRI
NCT02220023Phase 1Completed
- Sponsor
- Vanderbilt University
- Start
- Jul 2014
- Primary completion
- Feb 2017
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nitric oxide in pulmonary arterial hypertension (PAH), sponsored by Vanderbilt University. Primary endpoint: Right Ventricular Ejection Fraction. Started Jul 2014; status: completed.
02
Drugs
nitric oxide
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02220023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02220023.